Company News 

For Genus, Sexcel should sell

For Genus, Sexcel should sell

The big news from Genus (GNS) this year was the long-awaited launch of its selective breeding technology, Sexcel, which heightens the chance of cows producing female offspring. The product had been tied up in a patent dispute with a collection of US rivals, but in April Genus won a major victory removing contractual barriers to a commercial launch. Although that came after the financial year-end (and has therefore had no impact on these numbers), management is optimistic about the global demand among farmers, particularly in India – the world’s largest dairy market.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now